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One of the joyful aspects of a life in
science is listening to the rare seminar that
simply knocks your socks off. Two such
memorable moments for me came in the
form of job seminars by a pair of Richard
Axel’s post-docs: first, Linda Buck, who
described olfactory receptors and later
shared the Nobel Prize with Axel for this
work, and then, Catherine Dulac, who
identified pheromone receptors in the
vomeronasal organ (VNO) in mice. These
two sensory systems elicit very different
responses: while the main olfactory system
senses hundreds of thousands of different
odorants, by binding volatile compounds
to olfactory receptors within the main
olfactory epithelium (MOE) and project-
ing them onto the olfactory cortex, the
VNO detects a limited repertoire of
species-specific pheromones that trigger
sex-specific behaviors without any cortical
output whatsoever.
In January, as I was heading to Cam-
bridge where Dulac (Image 1) is now
Chair of Molecular and Cellular Biology
at Harvard, I was reminded of my
captivation with the VNO and refreshed
my memory of her work. Over the past
decade she has delineated some of the
molecular components of its signal trans-
duction system, including a VNO-specific
ion channel called TRPC2. Interestingly,
incapacitation of the VNO, by knock-out
of Trpc2, renders male mice unable to
discriminate sexes and relaxes male ag-
gression, while unmasking the male court-
ship behaviors in females, including even
ultrasonic vocalization. My interest in
speaking with Dulac was doubly piqued
by her recent beautiful studies on genetic
imprinting in the mouse brain. As both
pheromones and sexual dimorphisms in
the brain are topics that transcend
scientific inquiry by impacting popular
culture and medicine, I was keen to learn
more.
Luckily, our schedules meshed and I
was able to stop by her office in the
massive brick Bio Labs building on
Divinity Avenue. I crunched and skated
my way through its courtyard, piled high
with snow as Cambridge headed for its
near-record accumulation of 600 in Janu-
ary alone. I gave the old bronze rhinoceros
at the doorway a few affectionate pats,
dusting off that afternoon’s snowflakes.
Gitschier: Let’s talk about your child-
hood in France and how you became
curious about science.
Dulac: I grew up in the south of France
on the Mediterranean seashore where I
loved to eat oysters—I’m an oyster fanatic.
I was living in one of the two biggest
oyster-producing areas in France.
Gitschier: Where specifically?
Dulac: Montpellier. It has one of the
two oldest medical schools in Europe. It’s
a big scholarly place, although it is a small
city. I did all my education there through
high school, and then for my higher
education I went to Paris.
And how did I come to be a scientist?
Well, I think there are two reasons. One,
I’ve always been fascinated by research. As
a kid, I read books about history and in
particular about pre-history and digging
bones of old creatures. That seemed to be
what I wanted to do for all my life.
Gitschier: What age are we talking
about?
Dulac: As soon as I was able to read,
basically. I loved imagining how people
were in the past and trying to ask questions
about what they were thinking and doing
and making. Just the idea of being
confronted with a black box and being
able to ask a question and find the tools to
answer the question, whether that was
related to an animal or life or history.
Second is that my parents were scholars
in the humanities and they are themselves
researchers. But their research is to read
these old manuscripts and ask philosoph-
ical questions or questions related to
literature. But because their students in
the humanities had so much trouble
finding jobs, I remember very vividly my
parents saying, ‘‘Don’t do a career in
humanities because there are just no jobs.
Science is the way to go.’’
In France, you choose quite early what
kind of broad field you want to follow. I
was always oriented to more scientifically
oriented courses, which I loved. I went to a
sort of preparatory school and the courses
were excellent.
And here was really the revelation for
me about biology. I remember having
discussions with other students who were
more math and physics oriented. And I
was talking about how the planet came
about and how rocks were formed and
transformed and how life was formed and
transformed. And I was completely enthu-
siastic. And my friends doing physics were
looking at me and saying, ‘‘Hm, I wish I
could speak about physics with that much
enthusiasm.’’
Gitschier: Where did you do your
PhD?
Dulac: I did it in a developmental
biology lab, and the question was very
basic: how do cells decide their fate? And
it was an absolutely terrific experience,
both because the project was fascinating,
but also because my mentor was a really
exceptional person. Nicole Le Douarin is
one of the most famous developmental
biologists, not only in Europe, but also in
the world. I learned enormously from
her—not only about science, but thinking
about science, and teaching as well. She
was extremely enthusiastic about science,
and I had this in common with her. She
was also a terrific role model.
After my PhD, the big question was,
what do I do next? And for me, there were
a number of very pressing considerations.
One is, the work I was doing was in non-
molecular, non-genetic model systems,
which are the quail and the chicken
embryos. But I’m a very mechanistic
person; I wanted to go into a model
system that is very molecular or very
genetic, and that is obviously the mouse.
And the other consideration… My
parents in their infinite wisdom had
decided that I wouldn’t need to learn
English in school because I would have to
learn it someday anyway. So I therefore
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German and Russian as my four languag-
es. But that was terribly handicapping
because I needed to read and speak
English and I had no clue. I bought some
tapes and it was just excruciating. The
first time I got off the plane in the United
States I had never spoken a single word of
English—ever!
So, this is just to say something that
might seem very obvious here, but was not
obvious in France at the time, which is
that I needed to do a post-doc after my
PhD, and that I needed to do it either in
England or in the US. And the heart of
research is in the US.
And that’s how I ended up doing a post-
doc in Richard Axel’s lab at Columbia.
Gitschier: Well, there are many places
in the US to work on mice. What were the
other pieces of the puzzle?
Dulac: I visited many labs in the US.
What attracted me a lot to Richard Axel’s
lab was that when I was looking, in 1992,
Richard and Linda [Buck] had just
published the cloning of the olfactory
receptors. But what really did it was the
extraordinary personality of Richard Axel.
Someone who is extraordinarily thought-
ful and likes to ask big questions, with this
analytical and creative mindset to phrase
questions in a way that they now become
addressable. And the field of olfaction was
stuck, because people were trying to
address the most complex questions right
away. It was a complete mess.
Gitschier: Was it Richard’s idea to go
after the olfactory receptor, or Linda
Buck’s idea?
Dulac: I don’t exactly know what the
history is, but my understanding is that
Linda was one out of many post-docs who
had tried to clone these receptors in
Richard’s Lab. But the methodology used
to get at them—she’s the one who set up
this very clever PCR approach for con-
served regions of seven-transmembrane
receptors.
Gitschier: Had you yourself heard of
the VNO before?
Dulac: Richard was the one talking
about it. Richard is very funny and
politically incorrect. He had this dream
of cloning the mating receptors—the
VNO receptors—and exchanging them
with the receptor for lemon. And then
having a mouse mounting a lemon. And
that, he said, would be the cover of Cell.
The serious idea behind it was to clone
genes that were associated with innate
behavior, and for him that was fascinating.
And no, I had never heard of the VNO
before!
What I found fascinating with the VNO
was the development of these pre-pro-
grammed behaviors. Olfaction, smell—
you learn to smell. But you don’t learn
pheromones.
Gitschier: I wouldn’t even know how
to detect a pheromone.
Dulac: You wouldn’t detect them
consciously. And that’s the whole idea.
The VNO completely bypasses conscious
areas. It never hits the cortex. Nothing is
processed through cognitive areas; it is
completely innate. It goes to the amygdala
and the hypothalamus, and boom—you
either mate or attack. It is a subcortical
pathway that controls a central behavior.
So the idea with pheromone receptors
was that they would be easy [to clone], just
a subclass of olfactory receptors.
Gitschier: And so did you try Linda’s
approach?
Dulac: When I came to Richard’s lab,
I had two projects: a difficult project and
an easy project. Both of them were
impossible.
The difficult one was to figure out how
olfactory neurons choose to express one
receptor. That problem has still not been
solved—almost 20 years later.
Then I had the easy project that ended
up being as impossible as the first one!
And that was to identify the pheromone
receptors. And everyone believed that
would be an easy project, because every-
one assumed that the pheromone recep-
tors would just be a subfamily of the
olfactory genes. And indeed, when Linda
Image 1. Catherine Dulac. Image courtesy of Department of Molecular and Cellular Biology,
Harvard University.
doi:10.1371/journal.pgen.1002140.g001
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and amplified stuff from the VNO, where
the pheromone receptors are expressed,
she was able to get receptors out of it.
But there was something just wrong.
Because when I started to look at the
expression of these genes in the VNO, less
than 1% of the neurons were expressing
olfactory receptors, so there had to be
something else.
So here is how my 2 or 3 years of failure
came about because there was ‘‘no doubt’’
that the pheromone receptors had to be
something related to the olfactory recep-
tor, maybe a bit distant family. But I tried
the Linda Buck approach again and again
and again. I thought, ‘‘I’m a failure.’’
Gitschier: And Linda had left the lab
at this point?
Dulac: Linda had left the lab and
much later, I got to know a person, Emily
Liman, a post-doc in Linda’s lab, who was
trying to do exactly the same thing at the
same time, and also failed for years. We
actually ended up many years later
collaborating very closely on identifying
essential players of VNO signaling.
And I thought, maybe I’m a failure,
maybe I’m incompetent—but not that
incompetent. So there has to be something
else.
Gitschier: You must have been pretty
down in the dumps at that point.
Dulac: Yeah, I had times that were
really hard. Well, here is where Richard is
quite extraordinary. Richard would always
say, ‘‘I don’t know when you will be able
to make a hit, but I know you will.’’
Gitschier: Wow!
Dulac: ‘‘I don’t know if it’s going to be
tomorrow, I don’t know if it’s going to be
in 5 years.’’
Gitschier: What made him know that?
Dulac: Well, you know, Linda cloned
the olfactory receptors after 10 years as a
post-doc. So that totally relieved the time
pressure.
Gitschier: So he was saying that he
would support you no matter what.
Dulac: Yes. What was important was
to work on a big project, an important
project, and he would be supporting you
as long as you go for it.
And so at some point I did a key
experiment, I think, which a posteriori is so
simple. Now, Linda was able to clone the
olfactory receptor genes because she knew
what was the signal transduction. This was
published: activation of olfactory neurons
would lead to a cyclic nucleotide pathway
and from this you would have a cyclic
nucleotide-gated channel, and that would
be the beginning of the electrical, neuronal
signal. And so, because she knew this, she
could assume the receptors were GPCRs
[G-protein-coupled receptors], and there-
fore she designed primers based on the
known GPCRs.
So that was also our assumption for the
VNO, but because there was just no way I
could get these god-damn things, I said,
‘‘Maybe the signal translation is just not
cyclic nucleotide-related.’’
And so I did a very simple experiment. I
had a cDNA library and I just looked for
the signal transduction molecules that
were known in the olfactory system. I
had an olfactory library and I had a VNO
cDNA library, and if you hybridize filters
with a cyclic-nucleotide gated channel
probe, in the olfactory system about 1%
of the phages are clones for the channels,
but if you do the same experiment in the
VNO, there is nothing, absolutely nothing.
Gitschier: So you basically backed up.
Dulac: I backed up and I re-asked the
question. Are our assumptions about the
nature of this receptor accurate? And they
were not. None of the key elements of the
olfactory signaling pathway—none of
them—were there.
So I didn’t know where these phero-
mone receptors were; I didn’t even know
what family they belonged to. They could
be receptor tyrosine kinases or phospha-
tases. So I had to come up with a strategy
that made no assumption.
There were two possible strategies. In
differential display, you would sequence
everything. I forget how it worked but
there was something extraordinarily
labor-intensive.
Or there was a very elegant method that
seemed totally nuts, crazy—that was to
make libraries from a single neurons. And
that was based on the idea that in the
olfactory system, every neuron expresses a
different olfactory receptor gene, and the
expression at the cellular level is very high,
but since every cell expresses a different
receptor, the organ is a mosaic. So if that
were the case for the VNO as well, then by
comparing either two VNO neurons or a
VNO and an MOE neuron, I would get
the VNO receptor.
So I went to Richard’s office one day
and I said, ‘‘I know how I’m going to get
them.’’
And he said, ‘‘Well, you told me that
already, several times.’’
So this was another idea. He said, ‘‘OK,
what is the idea?’’
And I said, ‘‘I’m going to make single-
cell libraries and by differential screening,
I’m going to get the receptors.’’
‘‘OK, well come back when it works.’’
He thought the idea was extremely inter-
esting, but it seemed totally impossible.
It was interesting because within the lab
there was a lot of competition, but this
strategy of single-cell libraries seemed to
be so crazy that suddenly I was the nutcase
in the lab. And it was great because people
left me alone. There was no competition
any more, because I was doing this
completely unfeasible thing. And that
was fine with me. I could just think calmly
about stuff and go through the steps of
making the library.
And one day, I found some clones that
were differentially expressed. And I took
the clone and I did an in situ hybridization
with a VNO section, and they had exactly
the right pattern. Ah! But the signal was
weak because the clone was very small,
and I was not willing to show that to
Richard, because I knew he would look at
it and say ‘‘Puh.’’
So I waited to get a longer clone and do
another in situ that would look better. I kept
my finding a secret for a month or 2
months, which was bizarre because I’m not
asecretiveperson.Ontheotherhand,there
was some realsatisfaction tobethe only one
in the world to know that you got it!
Then, that was an interesting time of
my life because I had no doubt that I
would do a post-doc in the US and then
come back to France.
I love France. The idea of staying in a
foreign country was impossible to me.
However, there was a problem. I could see
from being at Columbia what people after
doing a successful post-doc would get: an
independent lab, an independent budget,
etc. And when I tried to see what I could
get in France, it was very clear that all I
could get was to go into somebody else’s
lab with maybe a bench or so. And it
made it impossible for me to come back to
France right away.
I feel very grateful to my country that
gave me what I consider to be an
incredibly high quality education. And I
feel that we serve our countries, and for
me going back to France and being a
scientist and teacher in France was my
way of giving back. But somehow France
wasn’t offering me the chance to do so.
It is tough when you go through a PhD
and a post-doc with absolutely top science
that you are then being asked to forget all
of this because you are not given the
means to achieve the top level in France.
Gitschier: Are you a US citizen now?
Dulac: Not yet. I should be, and I
promised that if Obama got elected I
would become a US citizen. So I have
some work to do!
Gitschier: Somehow your interests
have now led you to questions of genetic
imprinting. I have to tell you, I was so
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epigenetics because…
Dulac: …it had nothing to do with my
work.
Gitschier: Right! Let’s talk about your
move into that area now.
Dulac: My interest in the VNO and
behavior is not only male versus female,
although there is that, but it is more this
idea of an animal being born and being
able to recognize who are the members of
their own species, who they are supposed
to mate with, who they are supposed to
attack, who they are supposed to nurse,
who is a predator. These so-called innate
behaviors.
The animal needs to know what to do
and that information in a large part comes
from the genome. If you’re a mouse and
you need to learn what is a predator, then
you are dead, because you don’t have a
chance to learn.
So there must be a certain amount of
information, provided by your genome, on
how to respond to certain aspects of the
environment, and this complex interaction
between the genome and brain function is
something that I find fascinating. And it
has been fascinating me for a very, very
long time.
Gitschier: Before you went to Rich-
ard’s lab.
Dulac: Yes. Even as a kid. The
pheromone system for me was a big
discovery because I ran into a question
that was very dear to me, and I could even
work on it for my profession!
And males and females respond to
stimuli in completely different ways, and
in most animal species, the difference in
behavior is dramatic. But if you look at the
brain, the male and female brains look
alike.
However, Tali Kimchi in my lab
showed that if you remove the VNO of
the female, she will start to behave like a
male. Which says is that the brain is
essentially the same, and what the VNO
does is tell an animal to behave like a male
or a female.
So the epigenetic part belongs to the
same question on the relationship between
genes and behavior. What epigenetic
changes are for the brain are changes that
enable different states of behavior. So for
example, post-traumatic stress—it looks
very much like a brain that is taking a
different path in terms of functioning of
behavior circuits and then is stuck in that
path. You can see depression or mood
disorders that way. Puberty is something
similar. Puberty comes at the time when
the brain circuitry is almost achieved;
however, there is something happening
that is making the brain of a young animal
and the brain of a slightly older animal do
completely different things!
I am intrigued with these changes of
states of the brain. And epigenetic changes
are something that goes on top of the
genomic information and enables certain
genes to change their expression in a very
stable way. The phenomenon of genomic
imprinting seemed particularly interesting
for this, as it is a known epigenetic
regulation in placental mammals, in which
early maternal or paternal alleles of certain
genes are expressed.
Now, having two copies of each gene is
a huge evolutionary advantage, because if
anything goes wrong with one gene,
another comes to the rescue. So the
question is, why would animals choose to
silence one copy of essential genes?
My colleague David Haig had proposed
a model: what is very special about
placental mammals is that moms do most
of the job in providing all the resources in
raising the embryo, as long as the embryo
develops in utero. And that sets up a conflict
between the maternal and paternal ge-
nomes, because dad is trying to favor the
growth of its progeny by trying to suck as
many resources from mom as possible,
while mom needs resources for her and for
future embryos. This hypothesis was
proposed even before the first imprinted
genes were discovered! And so 1 year later,
the first two imprinted genes were discov-
ered, and they were Igf2—paternally
expressed—a growth factor that promotes
embryonic growth, and Igf2r, its receptor,
which is a truncated receptor that antag-
onizes embryonic growth and is maternal-
ly expressed.
I started to think about brain develop-
ment and brain function, and in principle
there is no reason that early imprinting
would affect only embryonic growth. It
should also affect the behavior of the
newborn animal, and maybe even the
adult. That’s why Chris Gregg, a post-doc
in my lab, and myself, in collaboration
with David Haig, started to be interested
in genomic imprinting in the brain and its
impact on behavior. And the fact that we
found that some imprinted genes are
imprinted only in males or only in females
was not something we expected, at all.
It is particularly interesting for brain
function because most of the brain disor-
ders have different prevalence in men and
women. So depression, MS [multiple
sclerosis], eating disorders, schizophrenia,
you name it. The fact that you have genes
that are present at one copy in one sex and
two copies in the other sex would certainly
offer a trove of candidates for genes being
implicated in these diseases. So that was a
great finding.
Gitschier: Well, what were you
expecting?
Dulac: We first asked the question: is
there anything special about imprinting in
the brain and behavior. If our hypothesis
was that imprinting could also have been
selected evolutionarily to modulate certain
behaviors, then imprinted genes must be
expressed in certain specific brain areas.
So there must be something special about
the expression of imprinted genes com-
pared with the expression of biallelic
genes.
And what we did was to use the Paul
Allen Brain Atlas that maps gene expres-
sion in the brain, and we looked at all the
imprinted genes, and we took randomly
selected biallelic genes.
Gitschier: Known previously.
Dulac: Yes—absolutely. If there is
something special about genomic imprint-
ing and behavior, then imprinted genes
should be preferentially expressed in
certain brain areas compared to normal
biallelic genes.
We took genes one by one, went
through all the sections, and looked at
whether gene 1 was expressed in brain
area a, b, c, d, and we did 120 brain areas.
A fantastic undergraduate student actually
did all this work, Brady Weissbourd,
together with Chris Gregg.
And something very striking emerged
from those studies—the majority of the
biallelic genes are expressed in the cortex.
In other words, the cortex is the place in
the brain where there is the maximal
molecular complexity. But if you look at
imprinted genes, the hot-spots are the
hypothalamus, the amydala, the dorsal
raphe, all the areas that are involved in
pain sensation, eating behavior, social
behavior, something literally completely
non-overlapping with the biallelic genes.
Gitschier: So once you had analyzed
the data, it was even more impressive than
you imagined.
Dulac: Yes, but this was an in silico
experiment. It didn’t tell us whether there
were other imprinted genes that had yet to
be discovered in those brain areas, and so
that was the next question. There was
another really important aspect of the
experiment—what brain areas to start
with.
Here is a very cool experiment pub-
lished in 1995 by Barry Keverne in
England. What he and his collaborators
did was to take zygotes with duplication of
maternal or duplication of paternal ge-
nome and to mingle them with normal
embryonic cells—genetic chimeras. These
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born. Then you can look at the brains of
these chimeras, and the results are abso-
lutely fascinating.
Have you ever heard of these
experiments?
Gitschier: Not these that you are
describing now.
Dulac: So here’s what happened. With
the entire paternal duplication embryos
have large bodies and small brains. The
embryos with duplication of the maternal
genome have small bodies and large
brains.
Then you can look at different parts of
the brain, ask what brain areas the
maternal and paternal genomes contribute
to preferentially, and that result is abso-
lutely fascinating: cells with duplication of
the paternal genome go exclusively to the
hypothalamus and avoid the cortex, but
cells with duplication of the maternal
genome go exclusively to the cortex and
avoid the hypothalamus. What this says is
that the paternal genome is required for
the hypothalamus and a maternal genome
is required for the cortex.
Barry Keverne’s hypothesis was that
dads only think about sex, and that’s what
the hypothalamus does, and moms think
about social interaction, maternal care,
which requires the cortex.
When I explain this experiment, guys
say, ‘‘Oh my God’’—and women love it!
But what that told us is that if we were to
be looking for imprinted genes in the
developing brain, in the adult cortex and
the adult hypothalamus, the prediction was
that we would find more maternally
expressed genes in the cortex and more
paternally expressed genes in the
hypothalamus.
Gitschier: It’s really interesting.
Now I just wanted to ask you something
that is always in the news, even though
we’re not talking about male versus
female brains…
Dulac: Well, so one aspect of our story
is that some of these are imprinted only in
males or only in females.
Gitschier: Right. So I was going to ask
you about Larry Summers.
Dulac: So we actually call the Keverne
experiment of the maternal contribu-
tion to the cortex the ‘‘Larry Summers
experiment.’’ In fact, I was reading the
Keverne paper at exactly the same time as
Larry Summers was making his comments
about women not being able to do
science.
And in fact, some of my male stu-
dents remember the experiment the other
way around, that there is a preferential
paternal contribution to the cortex. There
is a total disconnect between their expec-
tation and the result. Fascinating!
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